May 29, 2020
AstraZeneca with promising results from clinics for Imfinzi and Enhertu
AstraZeneca on Friday reported several clinical results from its studies, including Imfinzi and Enhertu, with meaningful outcomes.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Imfinzi
October 28, 2019
AstraZeneca posts positive positive progression-free survival (PFS) results in phase III Poseidon trial for 1st-line treatment of stage IV non-small cell lung cancer
AstraZeneca announced Monday that Imfinzi (durvalumab) and IMFINZI Plus Tremelimumab Delayed Disease Progression in Phase III POSEIDON Trial for 1st-Line…
May 25, 2018
AstraZeneca’s Imfinzi improves overall survival in trial for cell lung cancer
AstraZeneca and MedImmune, its global biologics research and development arm, on Friday reported positive overall survival (OS) results for the…
April 24, 2018
AstraZeneca disappointed in combination of Imfinzi plus tremelimumab
AstraZeneca and MedImmune, its global biologics research and development arm, brought to public high-level results from the Phase III ARCTIC…
February 19, 2018
US FDA approves Imfinzi for unresectable Stage III non-small cell lung cancer
AstraZeneca and MedImmune, its global biologics research and development arm, got clearance from the FDA to have Imfinzi for the…
October 17, 2017
FDA accepts supplemental BLA for AZ’s Imfinzi in certain lung cancer
The US Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) for AstraZeneca’s Imfinzi (durvalumab) for the treatment of…